Key result
Cardio-oncology telehealth identifies high or very high cardiotoxicity risk in ~82% of evaluated patients.
Why the study?
The study aimed to evaluate the role of a cardiologist in telehealth counseling of cancer patients at a federal oncology center.
Observational (n=215)
Cardio-oncology telehealth consultations identify a highly comorbid cancer patient population that frequently requires multidisciplinary care and cardioprotective therapy to mitigate cardiotoxicity risks.
Telehealth identifies high-risk cardio-oncology patients needing cardioprotection; hypothesis-generating and should not yet change practice.
Aim . To evaluate the role of a cardiologist in telehealth counseling of cancer patients at the federal oncology center. Material and methods . This retrospective study was conducted based on the materials of 215 telehealth consultations on cardiooncology, performed in the period from January 2019 to September 2021. Data on referrals to a cardiologist (cardio-oncologist) from various Russian regions and consultants’ answers were analyzed, taking into account the following data: region, sex, age of a patient, cancer type, stage, participation of other consultants, type of cardiovascular disease, the need for additional information and features of treatment — surgery, chemotherapy, radiation therapy. Risk was stratified based on a checklist including the main risk factors for cardiotoxicity. The recommendations of consultants for monitoring patients, as well as drug therapy prescriptions, were analyzed. Results . The most common cancer sites in patients referred for telehealth consultations on cardio-oncology were lungs, larynx and trachea, colon and rectum, kidneys and bladder, ovaries and uterus, and stomach. Cardiologists consulted together with oncologists — surgeons, medical oncologists, as well as anesthesiologists and radiation oncologists. The most common cardiovascular diseases were hypertension — 80,9% of patients, heart failure — 60%, arrhythmias — 41,6% and coronary heart disease — 37,7%. From 71 to 80,3%, 15,6-21% and 3,9-7,8% of patients had preserved, mid-range and reduced left ventricular ejection fraction. In 47,6-66,7% of cases, consultants required additional information. Based on risk stratification of cardiotoxicity of anticancer treatment, 118 (81,9%) patients out of 144 were classified as high and very high risk. Most patients were recommended cardioprotective therapy, which most often included angiotensin-converting enzyme inhibitors/angiotensin receptor blockers — 43,1-53,1%, beta-blockers — 44,8-58,6%, and statins — 22,4-38,3%. An algorithm for creating a request for a cardio-oncology telehealth consultation has been developed. Conclusion . The important role of cardio-oncology telehealth consultations in the work of the federal oncology center is demonstrated. Consulting cardiologists are part of a single multidisciplinary team of specialists and must act taking into account the characteristics of cancer and antitumor therapy prescribed by oncologists.
No takes yet. Share an insight, caveat, or question.
Potievskaya et al. (2022) conducted an observational in Cancer patients requiring cardio-oncology consultation (n=215). Cardio-oncology telehealth consultations was evaluated on Characteristics of referrals, prevalence of cardiovascular diseases, risk stratification, and recommended cardioprotective therapies. Among 215 cardio-oncology telehealth consultations, 81.9% of assessed patients were classified as having high or very high risk for cardiotoxicity and were frequently recommended cardioprotective therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: